Publication: Familial Breast Cancer and the hCHK2 1100delC Mutation: Assessing Cancer Risk
Loading...
Open/View Files
Date
2003
Authors
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
BioMed Central
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Varley, Jenny, and Daniel A. Haber. 2003. Familial breast cancer and the hCHK2 1100delC mutation: Assessing cancer risk. Breast Cancer Research 5(3): 123-125.
Abstract
Germline mutations in the human checkpoint gene, hCHK2, were first identified in 1999 in cases of Li–Fraumeni syndrome. Recent studies have demonstrated that the hCHK2 1100delC mutation acts as a low-penetrance tumour suppressor gene in familial breast cancer not associated with mutations in BRCA1 or BRCA2. The present article describes the published studies on hCHK2 1100delC and addresses some of the key questions raised.
Description
Other Available Sources
Research Data
Keywords
familial, hCHK2, Li–Fraumeni, penetrance, breast cancer
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service